10.21.2025
Prevent & Delay
$393,421.00
18 months
Induction of peripheral tolerance to beta cell antigens by specific targeting of human Langerin+ Dendritic Cells
Funds to support preclinical studies to develop a new targeted immunotherapy for type 1 diabetes.